UM-UC-3-Cas9

UM-UC-3-Cas9
Cat.No.:

EDC01340

Species:

Human

Cell Name:

UM-UC-3

Size:

1×10⁶cells

UM-UC-3-Cas9 Cell Line meets our QC standard. Low passage, high activity, contamination free. Useful for various vitro studies.
Cat.No. EDC01340
Product Name UM-UC-3-Cas9
Species Human
Cell Line UM-UC-3
Cellosaurus ID CVCL_1783
Cell Line Synonyms UMUC-3, UM-UC3, UMUC3, UC-3, University of Michigan-Urothelial Carcinoma-3
Gene Synonyms BPY2IP1|C19orf5|MAP8|VCY2IP-1|VCY2IP1
Summary
Enables DNA binding activity and cytoskeletal protein binding activity. Involved in metaphase chromosome alignment; microtubule cytoskeleton organization; and neuron projection morphogenesis. Located in several cellular components, including microtubule cytoskeleton; nuclear lumen; and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Associated Diseases Bladder Carcinoma
Morphology Adherent
Editing Efficiency 68%
Complete Culture Medium 55% basic culture medium+40% FBS+5% DMSO
Freezing Medium MEM(containing NEAA)+10%FBS
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
LociSTR Info (Sample Cell)
Sample Cell Line: UM-UC-3
STR Info (Cell bank)
Cell Line: UM-UC-3
Allele1Allele2Allele1Allele2
Amelogenin X X
CSF1PO 10 11 10 11
D2S1338 23 23
D3S1358 17 18 17 18
D5S818 12 12
D7S820 8 9 8 9
D8S1179 13 13
D13S317 8 8
D16S539 8 9 8 9
D18S51 14 14
D19S433 14 15 14 15
D21S11 31 31
FGA 20 21 20 21
Penta D 13 13
Penta E 12 12
TH01 6 9 6 9
TPOX 10 10
vWA 17 17
D6S1043 11 13
D12S391 22
D2S441 11
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.

Required Accessories

Related Services

Overexpression Cell LineOverexpression Cell Line
Contact Us
*
*
*
*
How did you hear about us: